Cockbain et al. studied the effect of the free fatty acid form of eicosapentaenoic acid (EPA-FFA) in patients undergoing liver resection surgery for CRC liver metastases. EPA-FFA was safe and well tolerated; it had no effect on the Ki67 proliferation index, but vascularity was reduced in EPA-naive patients and EPA-FFA had antiangiogenic activity in vitro. Early CRC recurrence rates were similar to those in the placebo group, but overall survival was improved in the 18 months after resection in patients who received EPA-FFA before surgery.
References
Cockbain, A. J. et al. Anticolorectal cancer activity of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid. Gut 10.1136/gutjnl-2013-306445
Rights and permissions
About this article
Cite this article
Eicosapentaenoic acid has anticolorectal cancer activity. Nat Rev Gastroenterol Hepatol 11, 140 (2014). https://doi.org/10.1038/nrgastro.2014.22
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2014.22